Cargando…
BR2 cell penetrating peptide effectively delivers anti-p21Ras scFv to tumor cells with ganglioside expression for therapy of ras-driven tumor
PURPOSE: Cell membrane penetrating peptide BR2 can bind with ganglioside and introduce foreign drugs into tumor cells. In this study, we employed BR2 to carry the broad-spectrum anti-p21Ras scFv prepared in our laboratory into ganglioside expressing tumor cells for therapy of ras-driven tumors. METH...
Autores principales: | Yu, Ting, Shi, Yingxian, Pan, Xinyan, Feng, Qiang, Wang, Peng, Song, Shuling, Yang, Lilin, Yang, Julun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159597/ https://www.ncbi.nlm.nih.gov/pubmed/35648774 http://dx.doi.org/10.1371/journal.pone.0269084 |
Ejemplares similares
-
Inhibition of human lung cancer cells by anti-p21Ras scFv mediated by the activatable cell-penetrating peptide
por: Du, Yu, et al.
Publicado: (2021) -
Recombinant Adenovirus KGHV500 and CIK Cells Codeliver Anti-p21-Ras scFv for the Treatment of Gastric Cancer with Wild-Type Ras Overexpression
por: Wang, Mingjuan, et al.
Publicado: (2018) -
Engineering a cell-penetrating hyperstable antibody scFv(Ras) – An extraordinary approach to cancer therapeutics
por: Bae, Jina, et al.
Publicado: (2021) -
A Cancer Specific Cell-Penetrating Peptide, BR2, for the Efficient Delivery of an scFv into Cancer Cells
por: Lim, Ki Jung, et al.
Publicado: (2013) -
Correction: A Cancer Specific Cell-Penetrating Peptide, BR2, for the Efficient Delivery of an scFv into Cancer Cells
por: Lim, Ki Jung, et al.
Publicado: (2013)